OpenVSafe by OpenVAERS
Search V-safe

LQF-14023-74024

2 vaccinations 1 coded response 14 check-ins 1 free-text entry 2 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
142 / NY
Registered
2020-12-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-21
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-22
    Registered in v-safe
  3. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  4. 2020-12-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2020-12-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  6. 2020-12-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2020-12-28
    Health check-in — day 7, dose 1
    Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  8. 2021-01-04
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-01-11
    Dose 2 — Pfizer-BioNTech
  10. 2021-01-18
    Health check-in — day 7, dose 2
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  11. 2021-01-18
    Report sent to call center — day 7, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  12. 2021-01-26
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-02-01
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-02-15
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-02-22
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-04-14
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-07-12
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2022-01-11
    Survey response — 12 months, dose 2
    MedDRA: Bronchitis, COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Bronchitis in October 2021 Covid Bronchitis in Dec 2021
    MedDRA releases: 2024-11 · check-in free text available
  19. 2022-01-11
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  20. 2022-01-12

Vaccinations

DoseDateManufacturerCo-administered
12020-12-21Pfizer-BioNTech
22021-01-11Pfizer-BioNTech

Call center

2 call center cases

1 unsuccessful · 1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 10 — 12 months, dose 2

2022-01-11

Symptoms: Bronchitis in October 2021 Covid Bronchitis in Dec 2021

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBronchitis · · ✓
SDCOVID-19 · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release